Akbar Husain Khan

Title: Akbar Husain Khan: Innovator in Pharmaceutical Conjugates

Introduction

Akbar Husain Khan is a notable inventor based in Waltham, MA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of conjugates for medical applications. With a total of 2 patents, his work focuses on innovative solutions for treating diseases such as cancer.

Latest Patents

Khan's latest patents include "Conjugates comprising cleavable beta-glucuronide-containing linkers." This patent relates to conjugates that include a specific linker formula and pharmaceutically acceptable salts. The specification highlights the use of these conjugates in treating diseases, including cancer, and discusses intermediates useful for their synthesis. Another significant patent is "Conjugates comprising cleavable linkers," which also focuses on a linker formula and its application in cancer treatment.

Career Highlights

Khan is currently associated with AstraZeneca AB, a leading global biopharmaceutical company. His work at AstraZeneca emphasizes the importance of innovative drug development and the potential impact of his inventions on patient care.

Collaborations

Khan has collaborated with notable colleagues, including Andreas Lothar Severino Maderna and Maximillian Taro William Lee. These collaborations have likely contributed to the advancement of his research and the successful development of his patents.

Conclusion

Akbar Husain Khan is a prominent inventor whose work in pharmaceutical conjugates has the potential to significantly impact cancer treatment. His innovative patents and collaborations reflect his commitment to advancing medical science.